Biotech and Healthcare investors in North America
223 funds · Updated
Gatsbie lists 223 Biotech and Healthcare investors headquartered in North America (as of 2026-11-18).
Each one names both biotech & life sciences and healthcare & medtech in its investment focus.
Most are based in United States (218) and Canada (5); the most common stages are Seed (198), Series A (186) and Pre-Seed (160); the most common kinds of capital are Venture equity (213), Growth equity (58) and Buyout (17).
Which Biotech and Healthcare investors are based in North America?
Gatsbie lists 223 Biotech and Healthcare investors headquartered in North America (as of 2026-11-18). Most are in United States (218) and Canada (5). They include Andreessen Horowitz (Menlo Park), DCVC (San Francisco), HOF Capital (New York), 8VC (San Francisco), SV Health Investors (Boston) and Aisling Capital (New York).
Which family offices invest in Biotech and Healthcare in North America?
9 of the 223 Biotech and Healthcare investors on Gatsbie are family offices, including Sopris Venture Capital, TARSADIA INVESTMENTS, BROADVIEW VENTURES, Raptor Group and Amzak Capital Management.
Upload your deck to see which of these fit your startup, with a written reason for each.
20 of 223 funds
Most active first: deals in the last 24 months, then portfolio companies on record.
| # | Fund | HQ | Stages | Partner emails |
|---|---|---|---|---|
| 1 | Andreessen Horowitz | Menlo Park | Seed–Series C+ | 38 |
| 2 | DCVC | San Francisco | Pre-Seed–Series B | 11 |
| 3 | HOF Capital | New York | Pre-Seed–Series B | 16 |
| 4 | 8VC | San Francisco | Seed–Series C+ | 19 |
| 5 | SV Health Investors | Boston | Pre-Seed–Series B | 22 |
| 6 | Aisling Capital | New York | Seed–Series C+ | 6 |
| 7 | F-Prime Capital | Cambridge | Pre-Seed–Series B | 32 |
| 8 | Innovation Endeavors | Palo Alto | Pre-Seed–Series B | 9 |
| 9 | General Catalyst | Prague | Pre-Seed–Series B | 10 |
| 10 | Avalon Ventures | La Jolla | Pre-Seed–Series B | 6 |
| 11 | Foresite Capital | San Francisco | Pre-Seed–Series B | 12 |
| 12 | TenOneTen Ventures | Los Angeles | Pre-Seed–Series B | 7 |
| 13 | True Ventures | Palo Alto | Pre-Seed, Seed | 13 |
| 14 | Cantos Ventures | San Francisco | Pre-Seed, Seed | 3 |
| 15 | BOLD Capital Partners | Santa Monica | Pre-Seed–Series A, Growth | 8 |
| 16 | Mayfield | Menlo Park | Pre-Seed–Series B | 6 |
| 17 | The Venture Collective | New York | Pre-Seed–Series A | 5 |
| 18 | Sofinnova | Paris | – | 20 |
| 19 | Obvious Ventures | San Francisco | Pre-Seed–Series B | 12 |
| 20 | Vertex Ventures | Palo Alto | Pre-Seed–Series B | 13 |
See more Biotech and Healthcare investors in Investor Discovery
Other sector pairs
Biotech and Healthcare investors elsewhere
Counted by where each fund is headquartered, from public sources, as of 2026-11-18. Only funds naming both sectors are listed.
